Published Date: 06 Mar 2023
Maharashtra: The Maharashtra University of Health Sciences (MUHS) has issued the notification of completion of the matrix list of seats by the course for:
Read Full NewsMistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.
A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.
1.
Triplet Therapy Improves Posttransplant Outcomes in Myeloma
2.
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted
3.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
4.
New clinical recommendation for local treatment of oligometastatic lung cancer.
5.
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity
1.
Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained
2.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
3.
Uncovering the Mysteries of the RDW Blood Test
4.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
5.
Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation